Use of vitamin d2 or vitamin d2 derivatives in the manufacture of a drug for the treatment of secondary hyperparathyroidism

摘要

A method for preventing loss of bone mass or bone mineral content in a human being suffering from secondary hyperparathyroidism by administering a sufficient amount of 1 alpha -OH vitamin D2, 1 alpha ,24(S)-(OH)2 vitamin D2, 1 alpha -OH vitamin D4 or 1 alpha ,24(R)-(OH)2 vitamin D4.